Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA
New T cell–based immunotherapy shows promise for lethal stem cell transplant complication ( Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA )
27 Apr 2015

Pembrolizumab promising for lung cancer, clinical outcomes correlate with biomarker

Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA
Pembrolizumab promising for lung cancer, clinical outcomes correlate with biomarker ( Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA )
27 Apr 2015

Pembrolizumab is better than ipilimumab for advanced melanoma in phase III trial

Prof Antoni Ribas - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA
Pembrolizumab is better than ipilimumab for advanced melanoma in phase III trial ( Prof Antoni Ribas - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )
27 Apr 2015

How to decide the treatment of CLL in 2015

Dr Marco Montillo and Dr Maria Gomes da Silva
How to decide the treatment of CLL in 2015 ( Dr Marco Montillo and Dr Maria Gomes da Silva )
24 Apr 2015

ecancermedicalscience editor's choice for March 2015

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for March 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
9 Apr 2015

Expert insight: Radiation oncology with the Scientific Director of the IEO

Prof Roberto Orecchia and Prof Gordon McVie
Expert insight: Radiation oncology with the Scientific Director of the IEO ( Prof Roberto Orecchia and Prof Gordon McVie )
31 Mar 2015

BRAF 'behind the scenes' in melanoma: A scientific story of discovery

Prof Richard Marais - Cancer Research UK Manchester Institute, Manchester, UK
BRAF 'behind the scenes' in melanoma: A scientific story of discovery ( Prof Richard Marais - Cancer Research UK Manchester Institute, Manchester, UK )
19 Mar 2015

Connecting science, practice and patient outcomes: Use of BRAF inhibitors for treating metastatic melanoma in clinical practice

Dr Bart Neyns - Universitair Ziekenhuis Brussels, Brussels, Belgium
Connecting science, practice and patient outcomes: Use of BRAF inhibitors for treating metastatic melanoma in clinical practice ( Dr Bart Neyns - Universitair Ziekenhuis Brussels, Brussels, Belgium )
19 Mar 2015

Response and resistance with BRAF inhibitors: Mechanisms, markers and unanswered questions

Dr Keith Flaherty - Massachusetts General Hospital Cancer Centre, Boston, USA
Response and resistance with BRAF inhibitors: Mechanisms, markers and unanswered questions ( Dr Keith Flaherty - Massachusetts General Hospital Cancer Centre, Boston, USA )
19 Mar 2015

Targeting CDK pathways in cancer treatment

Dr Geoffrey Shapiro - Dana Farber Cancer Institute, Boston, USA
Targeting CDK pathways in cancer treatment ( Dr Geoffrey Shapiro - Dana Farber Cancer Institute, Boston, USA )
11 Mar 2015

DNA repair inhibitors to overcome drug resistance

Dr Ruth Plummer - Newcastle University, Newcastle, UK
DNA repair inhibitors to overcome drug resistance ( Dr Ruth Plummer - Newcastle University, Newcastle, UK )
11 Mar 2015

Refining the role of PARP inhibitors in targeted anticancer therapy

Prof Yves Pommier - National Cancer Institute, Bethesda, USA
Refining the role of PARP inhibitors in targeted anticancer therapy ( Prof Yves Pommier -  National Cancer Institute, Bethesda, USA )
11 Mar 2015